Researchers assessed 55 first-episode drug-naive people with schizophrenia diagnoses in New Delhi, India for the predictive value of symptoms on quality of life (QOL). They found that negative symptoms have a greater impact than positive on subjective quality of life, while antipsychotics focus on primary positive and negative symptoms. “There is a need to develop a holistic approach (target non-psychotic symptoms intensively) in the disease management to prevent further long-term impairment of QOL.” The study appears in the Nordic Journal of Psychiatry.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
This is interesting because people are often forcibly treated for positive symptoms with drugs which give them negative symptoms.